Alvotech (ALVO) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Alvotech (ALVO) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $1.05B, listed on NASDAQ, employing roughly 1,012 people, carrying a beta of 0.21 to the broader market. Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. Led by Lisa Graver, public since 2022-06-16.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for ALVO as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →